enVVeno Medical Corporation
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -2.06 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
1.32 | 4.83 | -72.59% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-2.39 | -22.17 | -89.24% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-3.12 | 68.76 | -104.54% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | -6902.94 | -100% |
| ROE |
|
-50.9 | 9.61 | -629.57% |
|
|
| ROA |
|
-48.35 | 0.3443 | -14145.22% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-54.63 | 15.45 | -453.59% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0568 | -3.68 | -98.46% | -0.0719 | -21% |
| Nеt Debt/Ebitda |
|
0.0898 | -3.44 | -102.61% |
|
|
| Debt/Ratio |
|
0.0288 | 0.1986 | -85.48% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.0596 | 10.32 | -100.58% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-96.06 | -57.64 | 66.66% | ||
| Growth impulse Ebitda in 5 years |
|
279.06 | -90.94 | -406.86% | ||
| Growth impulse Net Income in 5 years |
|
209.42 | -97.8 | -314.13% | ||
| Growth impulse FCF in 5 years |
|
199.86 | -108.72 | -283.83% | ||
| Growth impulse EPS in 5 years |
|
-84.2 | -142.05 | -40.73% |
IP Score
3.93/10
